1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-14.73%
Negative R&D growth (spending reduction) needs careful analysis. Benjamin Graham would examine impact on competitive position.
3.54%
G&A growth 3-5% suggests rising overhead costs. Howard Marks would investigate if increases are necessary.
No Data
No Data available this quarter, please select a different quarter.
100.00%
Other expenses growth above 20% signals concerning cost expansion. Seth Klarman would scrutinize unusual items.
-10.44%
Negative operating expenses growth needs verification. Benjamin Graham would examine sustainability.
-10.44%
Negative total costs growth needs verification. Benjamin Graham would examine sustainability.
-100.00%
Negative interest expense growth needs verification. Benjamin Graham would examine debt reduction strategy.
721.68%
D&A growth above 10% signals heavy asset expansion. Seth Klarman would demand evidence of future payoff.
11.90%
EBITDA growth 8-12% reflects healthy business expansion. Philip Fisher would verify competitive position.
No Data
No Data available this quarter, please select a different quarter.
10.44%
Operating income growth 8-12% reflects healthy business expansion. Philip Fisher would verify competitive position.
No Data
No Data available this quarter, please select a different quarter.
-34.01%
Negative other expenses growth needs verification. Benjamin Graham would examine sustainability.
10.28%
Pre-tax income growth 8-12% reflects healthy business expansion. Philip Fisher would verify competitive position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
10.28%
Net income growth 8-12% reflects healthy business expansion. Philip Fisher would verify competitive position.
No Data
No Data available this quarter, please select a different quarter.
12.12%
EPS growth 12-15% shows strong earnings momentum. Peter Lynch would examine growth drivers.
10.49%
Diluted EPS growth 8-12% reflects healthy expansion. Philip Fisher would verify competitive position.
2.21%
Share increase above 2% signals significant dilution. Seth Klarman would demand explanation.
No Data
No Data available this quarter, please select a different quarter.